Macrogenics (MGNX) Fundamental Analysis: Revenue, Earnings & Valuation

6.28 / 10

Outperform

Fundamental analysis rates MGNX as Outperform with a 6.3/10 quality. Strong Asset‑MV, Profit‑MV and Cash‑MV scores boost outlook, but low Fixed‑assets turnover and high income‑tax‑to‑profit ratios dampen it. Overall fundamentals are encouraging yet contain notable weaknesses.

Analysis Checks(5/10)

Revenue-MV

Value0.69

Score1/3

Weight18.49%

1M Return5.44%

Inventory turnover ratio

Value9.10

Score2/3

Weight-1.36%

1M Return-0.56%

Gross profit margin (%)

Value75.91

Score0/3

Weight-10.76%

1M Return-5.42%

Profit-MV

Value0.68

Score2/3

Weight21.11%

1M Return6.36%

Income tax / Total profit (%)

Value0.89

Score1/3

Weight0.52%

1M Return0.21%

Current assets turnover ratio

Value0.68

Score1/3

Weight-0.46%

1M Return-0.17%

Fixed assets turnover ratio

Value3.83

Score1/3

Weight-2.75%

1M Return-1.13%

Cost of sales ratio (%)

Value24.09

Score2/3

Weight-8.65%

1M Return-3.62%

Asset-MV

Value-0.55

Score3/3

Weight63.17%

1M Return15.70%

Cash-MV

Value2.18

Score2/3

Weight20.68%

1M Return6.19%

Is MGNX undervalued or overvalued?

MGNX scores 6.28/10 on fundamentals and holds a Discounted valuation at present. Backed by its -86.95% ROE, -49.91% net margin, -2.70 P/E ratio, 3.62 P/B ratio, and -10.28% earnings growth, these metrics solidify its Outperform investment rating.